Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F63E3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,222
Award facts
- Contract value 100% obligated
- $43,222.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $43,222 on December 9, 2025, for supply of Zepbound (tirzepatide) 10 mg/0.5 mL pen injections with completion targeted for December 10, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania.
This delivery order represents a routine pharmaceutical procurement through DLA's global pharmaceutical support vehicle, which enables AmerisourceBergen to supply medications across multiple therapeutic domains to support military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. Zepbound, a GLP-1 receptor agonist indicated for weight management, reflects the breadth of pharmaceutical products the contractor furnishes through its federal contracts. As a child delivery order under the larger IDC vehicle, this award leverages AmerisourceBergen's established capability as a major pharmaceutical distributor and its demonstrated performance delivering both brand-name and generic medications to federal medical supply chains.
Quick answers
Who was awarded contract SPE2DR26F63E3?
SPE2DR26F63E3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F63E3 worth?
The government has obligated $43,222 on SPE2DR26F63E3.
Is contract SPE2DR26F63E3 an order under another contract?
Yes. SPE2DR26F63E3 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F63E3 competed?
The extent of competition for SPE2DR26F63E3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award